Sector:
Healthcare

Location:
Rockville, MD

Year Funded:
2004

Status:
IPO

Website:
www.vandapharma.com

Summary:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. Vanda’s lead product is Fanapt (iloperidone), which is marketed by Novartis for the treatment of schizophrenia.